Tag: EAST System
“Something we’ve never seen before”: How PGG could redefine treatment for...
Outcomes from the first-in-human (FIH) trial of the investigational Nectero endovascular aneurysm stabilisation treatment (EAST) system (Nectero Therapeutics) with pentagalloylglucose (PGG) demonstrated a clinically...
Nectero Medical announces initiation of Phase II/III clinical trial of the...
Nectero Medical today announced initiation of a Phase II/III clinical trial (stAAAble) to investigate the safety and efficacy of the Nectero Endovascular Aneurysm Stabilisation...
Alcami supports Phase II/III trial supply of the Nectero EAST system
Alcami has welcomed the recent announcement by Nectero Medical that it has received clearance from the US Food and Drug Administration (FDA) of their...
Nectero EAST® System touted as potential “game changer” for smaller infrarenal...
“A truly novel and potentially groundbreaking treatment strategy for patients with small to mid-sized infrarenal abdominal aortic aneurysms,” is how Michael R. Jaff (Boston,...
